Policy Leadership Briefings on Comparative Effectiveness Research
The Center for Medical Technology Policy (CMTP) is working with the nation’s business leaders, clinical research institutions, managed care organizations, patient advocates, and government to promote the development and evaluation of new drugs and technologies for improving the care of patients, and to support the mission and goals of the new Patient-Centered Outcomes Research Institute (PCORI) in creating a comparative effectiveness research (CER) framework for the US.
CMTP has developed the Policy Leadership Briefings Series with two goals: (1) to provide concise but in-depth information to key decision makers and policy makers on aspects of comparative effectiveness research and evidence-based, patient centered health care; and (2) to create a neutral, independent platform for exchange of tools, strategies and ideas for CER between policy makers and the top experts in the US and abroad.
A white paper that provides background and describes the key issues will be distributed to participants at each meeting. Meetings are typically limited to a morning or afternoon, and include breakfast or lunch, and are located near the Capitol for easy access to members and their staffs.
Building a New Foundation for Comparative Effectiveness Research: Exploring Ideas for the PCORI Methodology Committee
Date: October 1, 2010
Time: 8:30am - 11:30am
Location: Rayburn House Office Building (2123)
With the naming of the PCORI board in late September, attention shifts to the appointment of the methodology committee. Established by the health care reform law, the committee will "...work to develop and improve the science and methods of comparative clinical effectiveness research." It is charged with developing methodological standards for CER with the input of relevant experts, stakeholders, and the general public, and to submit recommendations on these standards to the PCORI board within 18 months of its inception. The committee is also responsible for developing a translation table that describes the research methods most suited for each type of question. This briefing will address the key issues and challenges that will confront the new committee, including: the scope of the research standards to be developed; how the committee will prioritize research questions and engage stakeholders in its work; and the relationship between the committee, the PCORI board, NIH, AHRQ, FDA and other federal and non-federal entities. These and other questions will be discussed by some of the nation's leading experts on clinical research methods, comparative effectiveness research, and health policy.
Confirmed speakers include:
- Sean Tunis, Center for Medical Technology Policy
- Stephen Cha, House Committee on Energy and Commerce
- Ann Bonham, Association of American Medical Colleges
- Adrian Thomas, Johnson and Johnson
- Steve Pearson, Institute for Clinical and Economic Review
- Albert Wu, Johns Hopkins University
What is CER and What Will It Mean for Patients, Physicians and Payors?
Date: July 30, 2010
Time: 8:30am - 12:00pm
Location: Capitol Visitors Center (SVC 200/201)
Comparative Effectiveness Research (CER) is, by definition, intended to provide evidence that informs real world decision making by physicians and patients in choosing between treatment options. The underlying premise of CER as defined in the health reform law is that such evidence is too often lacking. CER attempts to rectify that by conducting studies that differ in critical ways from many traditional clinical studies. What those differences are, how they will be carried out, and the role of the new Patient Centered Outcomes Research (PCOR) Institute in defining and implementing these approaches will be addressed by some of the nation’s leading authorities and decision makers in CER.
The Center for Medical Technology Policy will be holding a series of Policy Leadership Briefings in order to provide a neutral forum for key policy decision-makers and experts to engage in a frank and informative dialogue on critical CER issues, concerns and policy options. The first of these sessions will focus on various aspects of CER, addressing questions on the differences between CER and traditional clinical research, methods by which CER studies should be carried out across the clinical research enterprise, as well as the critical factors necessary for the PCOR Institute to provide maximum value.
